Two Sigma Investments, LP Crinetics Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 5,414 shares of CRNX stock, worth $296,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,414
Previous 10,800 49.87%
Holding current value
$296,254
Previous $483,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$43.83 - $54.98 $236,068 - $296,122
-5,386 Reduced 49.87%
5,414 $276,000
Q2 2024

Aug 14, 2024
SELL
$42.12 - $51.91 $4.55 Million - $5.61 Million
-108,080 Reduced 90.92%
10,800 $483,000
Q1 2024

May 15, 2024
SELL
$34.76 - $46.81 $2.58 Million - $3.47 Million
-74,221 Reduced 38.44%
118,880 $5.56 Million
Q4 2023

Feb 14, 2024
SELL
$25.62 - $37.07 $5.35 Million - $7.74 Million
-208,852 Reduced 51.96%
193,101 $6.87 Million
Q3 2023

Nov 14, 2023
BUY
$15.97 - $30.59 $4.96 Million - $9.5 Million
310,418 Added 339.12%
401,953 $12 Million
Q2 2023

Aug 14, 2023
BUY
$15.73 - $23.6 $933,339 - $1.4 Million
59,335 Added 184.27%
91,535 $1.65 Million
Q1 2023

May 15, 2023
BUY
$15.31 - $21.1 $116,172 - $160,106
7,588 Added 30.83%
32,200 $517,000
Q4 2022

Feb 14, 2023
BUY
$15.49 - $19.05 $21,004 - $25,831
1,356 Added 5.83%
24,612 $450,000
Q3 2022

Nov 14, 2022
SELL
$18.11 - $22.37 $425,385 - $525,448
-23,489 Reduced 50.25%
23,256 $457,000
Q2 2022

Aug 15, 2022
SELL
$16.49 - $27.64 $1.22 Million - $2.05 Million
-74,032 Reduced 61.3%
46,745 $872,000
Q1 2022

May 16, 2022
SELL
$17.15 - $28.31 $283,232 - $467,539
-16,515 Reduced 12.03%
120,777 $2.65 Million
Q4 2021

Feb 14, 2022
SELL
$19.35 - $28.41 $174,150 - $255,690
-9,000 Reduced 6.15%
137,292 $3.9 Million
Q3 2021

Nov 15, 2021
BUY
$16.88 - $25.23 $506,096 - $756,445
29,982 Added 25.78%
146,292 $3.08 Million
Q2 2021

Aug 16, 2021
BUY
$15.9 - $21.15 $928,019 - $1.23 Million
58,366 Added 100.73%
116,310 $2.19 Million
Q1 2021

May 17, 2021
BUY
$13.3 - $17.55 $53,638 - $70,779
4,033 Added 7.48%
57,944 $885,000
Q4 2020

Feb 16, 2021
BUY
$12.08 - $17.46 $324,154 - $468,521
26,834 Added 99.1%
53,911 $761,000
Q3 2020

Nov 16, 2020
SELL
$13.62 - $17.66 $364,130 - $472,140
-26,735 Reduced 49.68%
27,077 $424,000
Q2 2020

Aug 14, 2020
BUY
$13.04 - $23.23 $701,708 - $1.25 Million
53,812 New
53,812 $943,000

Others Institutions Holding CRNX

# of Institutions
240
Shares Held
79.5M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.94B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email